{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ct-nct02593149",
  "owner": "cardio",
  "kind": "study",
  "slug": "nct02593149",
  "name": "Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap",
  "aliases": [
    "NCT02593149"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1902 participants.",
  "summary_technical": "Registry record NCT02593149. Randomized; no masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2016-11 (actual). Results posted on 2019-02-27.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-08",
  "last_evidence_check": null,
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "nct",
      "value": "NCT02593149",
      "normalized_value": "NCT02593149",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "condition-area": [
        "kidney-connections"
      ],
      "system": [
        "kidneys"
      ]
    }
  },
  "payload": {
    "design": "Interventional study; randomized; no masking; primary purpose treatment",
    "drug_phase": "not_applicable",
    "registry_statuses": [
      {
        "status": "COMPLETED",
        "snapshot": "cardio:ctgov-nct02593149-2019-02-27"
      }
    ],
    "start_date": {
      "date": "2015-11",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct02593149-2019-02-27"
    },
    "primary_completion_date": {
      "date": "2016-11",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct02593149-2019-02-27"
    },
    "completion_date": {
      "date": "2016-11",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct02593149-2019-02-27"
    },
    "results_first_posted": {
      "date": "2019-02-27",
      "type": null,
      "snapshot": "cardio:ctgov-nct02593149-2019-02-27"
    },
    "countries": [
      {
        "code": "US",
        "snapshot": "cardio:ctgov-nct02593149-2019-02-27"
      }
    ],
    "care_setting": null,
    "stopped_early": null,
    "enrollment": [
      {
        "count": 1902,
        "basis": "enrolled",
        "unit": "participants",
        "snapshot": "cardio:ctgov-nct02593149-2019-02-27"
      }
    ],
    "arms": [],
    "findings": [],
    "registry": [
      {
        "label": "Brief title",
        "value": "Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap",
        "locator": "protocolSection.identificationModule.briefTitle"
      },
      {
        "label": "Condition",
        "value": "End Stage Renal Disease (ESRD)",
        "locator": "protocolSection.conditionsModule.conditions[0]"
      },
      {
        "label": "Intervention (Device)",
        "value": "ClearGuard HD End Cap",
        "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
      },
      {
        "label": "Lead sponsor",
        "value": "Pursuit Vascular, Inc.",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
      },
      {
        "label": "Lead sponsor class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.class"
      },
      {
        "label": "Collaborator",
        "value": "Davita Clinical Research",
        "locator": "protocolSection.sponsorCollaboratorsModule.collaborators[0].name"
      },
      {
        "label": "Collaborator class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.collaborators[0].class"
      }
    ]
  },
  "content_digest": "df48edfd19dcae1da475b177fa4fa22e6b446db089e6df22f2e98eca52e6a1fa",
  "review": {
    "content_digest": "df48edfd19dcae1da475b177fa4fa22e6b446db089e6df22f2e98eca52e6a1fa",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "investigates",
        "label": "Registry condition terms include this condition",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:chronic-kidney-disease",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02593149-2019-02-27",
          "locator": "derivedSection.conditionBrowseModule.ancestors[0].id"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "results_reported_in",
        "label": "Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:pubmed-29472415",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02593149-2019-02-27",
          "locator": "protocolSection.referencesModule.references[0].pmid"
        },
        "primary": false,
        "role": "main",
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "studies/nct02593149/",
  "context_path": "api/v1/context/cardio--ct-nct02593149.md"
}
